loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 204061 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Teva Pharmaceutical Industries

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 TEVA BRANDED PHARM (1)

    filter

    01 TABLET;ORAL (1)

    filter

    01 RX (1)

    filter

    01 QUARTETTE (1)

    filter

    01 Yes (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ETHINYL ESTRADIOL; LEVONORGESTREL

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET; ORAL
    0.02MG,0.15MG;0.02...
    2013-03-28
    204061
    QUARTETTE
    RX
    Yes
    AB
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 204061

    Looking for FDA Orange Book APPLICATION 204061 1

    19

    Teva Pharmaceutical Industries, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is ETHINYL ESTRADIOL; LEVONORGESTREL, with a corresponding application number 204061.

    Regulatory Information RX

    With a dosage strength 0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.15MG;0.01MG,N/A

    Dosage Form Route TABLET; ORAL

    Reference Listed Drug Yes

    Approved since 2013-03-28

    Therapeutic Equivalence (TE) Code AB

    Post Enquiry
    POST ENQUIRY